Drawing for MOLECULAR CLOCK

USPTO serial 88648085

MOLECULAR CLOCK

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
POWERS, ALEXANDER L
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MOLECULAR CLOCK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Arash Behravesh

Arash Behravesh Mannava & Kang PC3201 Jermantown Rd., Suite 5253201 Jermantown Rd.FAIRFAX, VA 22030

Goods and services

ClassDescriptionStatusFirst use
009Recorded computer software for use by others for use in predicting pregnancy due date or estimating gestational age, and accessing medical information, namely, information concerning fertility, ovulation, pregnancy, and birth risks in the field of obstetrics and labor and delivery; Downloadable computer software for use by others for use in predicting pregnancy due date or estimating gestational age, and accessing medical information, namely, information concerning fertility, ovulation, pregnancy, and birth risks; Recorded computer software for use in connection with predicting, screening, diagnosing, and monitoring of various pre-conception, pregnancy, and neonatal complications, including preterm birth, fetal growth restriction, pre-eclampsia, gestational diabetes, and fetal birth defects; Downloadable computer software for use in connection with assessing whether fetal development is proceeding normally or abnormallyACTIVE—
010Medical apparatus for predicting pregnancy due date or estimating gestational age; medical apparatus for predicting, screening, diagnosing, and monitoring of various pre- conception, pregnancy, and neonatal complications, including preterm birth, fetal growth restriction, pre-eclampsia, gestational diabetes, and fetal birth defects; medical apparatus for assessing whether fetal development is proceeding normally or abnormallyACTIVE—
042Software as a service (SAAS) services, namely, hosting software for use by others for use in predicting pregnancy due date or estimating gestational age, and accessing medical information, namely, information concerning fertility, ovulation, pregnancy, and birth risks in the field of obstetrics and labor and delivery; software as a service (SAAS) services, namely, hosting software for use by others for use in predicting pregnancy due date or estimating gestational age, and accessing medical information, namely, information concerning fertility, ovulation, pregnancy, and birth risks; software as a service (SAAS) services featuring software for use in connection with predicting, screening, diagnosing, and monitoring of various pre-conception, pregnancy, and neonatal complications, including preterm birth, fetal growth restriction, pre-eclampsia, gestational diabetes, and fetal birth defects; software as a service (SAAS) services featuring software for use in connection with assessing whether fetal development is proceeding normally or abnormallyACTIVE—
044Medical information; provision of medical information and data on fertility; providing a website featuring medical information, namely, providing information concerning fertility, ovulation, pregnancy, and birth risks; providing information by means of a website concerning the use of medical equipment for the prediction of pregnancy due date or the estimation of gestational age; providing information by means of a website in connection with predicting, screening, diagnosing, and monitoring of various pre-conception, pregnancy, and neonatal complications, including preterm birth, fetal growth restriction, pre-eclampsia, gestational diabetes, and fetal birth defects; providing information by means of a website in connection with whether fetal development is proceeding normally or abnormallyACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jun 26, 2023MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 26, 2023ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 3, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 2, 2022EX5GSOU EXTENSION 5 GRANTED—
Nov 26, 2022EXT5SOU EXTENSION 5 FILED—
Nov 26, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 31, 2022DOCKASSIGNED TO EXAMINER—
May 28, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 26, 2022EX4GSOU EXTENSION 4 GRANTED—
May 26, 2022EXT4SOU EXTENSION 4 FILED—
May 26, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 30, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 26, 2021EX3GSOU EXTENSION 3 GRANTED—
Nov 26, 2021EXT3SOU EXTENSION 3 FILED—
Nov 26, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 28, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 26, 2021EX2GSOU EXTENSION 2 GRANTED—
May 26, 2021EXT2SOU EXTENSION 2 FILED—
May 26, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Mar 18, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 17, 2021EX1GSOU EXTENSION 1 GRANTED—
Mar 15, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 12, 2020NREVNOTICE OF REVIVAL - E-MAILED—
Dec 11, 2020TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Dec 11, 2020PETGPETITION TO REVIVE-GRANTED—
Dec 11, 2020PROATEAS PETITION TO REVIVE RECEIVED—
Nov 27, 2020EXT1SOU EXTENSION 1 FILED—
May 26, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 31, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 31, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 11, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 25, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 25, 2020XAECEXAMINER'S AMENDMENT ENTERED—
Feb 25, 2020GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Feb 25, 2020GNEAEXAMINERS AMENDMENT E-MAILED—
Feb 25, 2020CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 21, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 21, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 21, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 14, 2020DOCKASSIGNED TO EXAMINER—
Oct 15, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 12, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance